Companies: 10,795·Total market cap: $144.5T
CONMED Corporation

CONMED Corporation

CNMDNYSEHealthcare● Active
$35.26
+$0.10(+0.28%)
Market Cap$1.1B
P/E Ratio
52W High$60.35
52W Low$32.13
Overview

CONMED Corporation (CNMD) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

cnmd · stock forecast · 21 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 21 Wall Street analysts in the past 3 months

SellBuy

Hold

21 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
7
Hold
14
Sell
0
Strong Sell
0
Total: 21 · Buy rate: 33.3%

12-Month Price Target

High

$95.00

Consensus

$78.00

+121.8% upside

Low

$61.00

Median: $78 · Last Close: $35.16

The CONMED Corporation (CNMD) analyst consensus is Hold, based on ratings from 21 Wall Street analysts over the past 3 months. The average 12-month CNMD price target is $78.00, representing +121.8% upside from the current price of $35.16.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $78 (121.8%)

Consensus Target

$78.00

121.8% upside

High Target

$95

170.2%

Low Target

$61

73.5%

Current Price

$35.16

as of today

Based on analyst price targets, the CNMD stock price prediction for the next 12 months ranges from $61 to $95. The consensus CNMD price forecast of $78.00 implies 121.8% upside from the current price of $35.16.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$34.252.59%

1-day model range: $34.1–$34.4. Peak: $34.4 (-2.59%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$21-41.6%
2028$16-55.0%
2029$14-60.6%
2030$13-63.4%
2031-64.8%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

21%8%71%
3Buy
1Neutral
10Sell
RSI (14)48.2Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · CNMD · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$34.37BUY
MA 10$35.18SELL
MA 20$35.70SELL
MA 50$36.45SELL
MA 100$38.64SELL
MA 200$42.27SELL
Current $CNMD · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$34.78BUY
EMA 10$35.08BUY
EMA 20$35.61SELL
EMA 50$36.72SELL
EMA 100$38.51SELL
EMA 200$42.51SELL
Current $CNMD · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
B of A Securities2026-05-18
Maintains
NeutralNeutral
Wells Fargo2026-05-01
Maintains
Equal WeightEqual Weight
JP Morgan2026-04-30
Maintains
NeutralNeutral
Piper Sandler2026-03-17
Downgrade ↓
OverweightNeutral
Needham2026-01-29
Maintains
HoldHold
Wells Fargo2026-01-29
Maintains
Equal WeightEqual Weight
B of A Securities2025-12-08
Maintains
NeutralNeutral
Wells Fargo2025-11-06
Maintains
Equal WeightEqual Weight
JP Morgan2025-11-06
Maintains
NeutralNeutral
Piper Sandler2025-11-06
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on CONMED Corporation (CNMD) stock. Of the recent 101 rating actions, 5 were upgrades and 11 were downgrades. 21 analysts currently cover CNMD.

Analyst Recommendation Trends

Buy ratings101
Hold ratings22
Sell ratings00

CNMD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$1.3B

↓ 4.4% YoY

Revenue Next Year

$1.4B

↑ 5.1% YoY

EPS This Year

$4.03

EPS Next Year

$4.50

↑ 11.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CNMD EPS of $4.03 for the current fiscal year, based on estimates from 6 analysts. The CNMD revenue forecast is $1.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CNMD stock forecast is supported by two independent data sources: analyst consensus ratings from 21 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CNMD price target is $78.00 (+121.8% upside), with an analyst consensus of Hold.

The CNMD short-term stock prediction for tomorrow is $34.25 (-2.59%). The CNMD stock price prediction for 2027 estimates an average of $21. The CNMD stock prediction for 2030 projects a range of $12–$14.

CONMED Corporation trades on NYSE under the ticker CNMD. The CNMD stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 33% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

CNMD forecast · 8 questions

According to 21 Wall Street analysts, the average 12-month CNMD price target is $78.00, with a high forecast of $95.00 and a low of $61.00. The median price target is shown in the chart above when available. This implies +121.8% potential upside from the current price of $35.16.

CNMD price targetWhat is CNMD price targetCNMD analyst price targetCNMD 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.